Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations.
Corianò M, Lazzarin A, Maffezzoli M, Santoni M, Mazzaschi G, Rodella S, Simoni N, Lai E, Maruzzo M, Basso U, Bimbatti D, Iacovelli R, Anghelone A, Fiala O, Rebuzzi SE, Fornarini G, Lolli C, Massari F, Rosellini M, Mollica V, Nasso C, Acunzo A, Silini EM, Quaini F, De Filippo M, Brunelli M, Banna GL, Rescigno P, Signori A, Buti S.
Corianò M, et al. Among authors: silini em.
Immunotherapy. 2025 Jan 20:1-11. doi: 10.1080/1750743X.2025.2452145. Online ahead of print.
Immunotherapy. 2025.
PMID: 39829377